Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cerebral malaria: optimising management.

Neema Mturi1, Crispin O Musumba, Betty M Wamola

  • 1Kenya Medical Research Institute Centre for Geographic Medicine Research, Coast, Kilifi, Kenya.

CNS Drugs
|March 6, 2003
PubMed
Summary

Cerebral malaria, a severe brain complication, affects children and adults globally. Effective treatment relies on parenteral antimalarials like quinine, quinidine, and artemisinins, with supportive care crucial for better outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In-hospital and post-discharge mortality among infants with respiratory syncytial virus in rural Kenya: a 25-year retrospective cohort study.

The Lancet. Global health·2026
Same author

A blended genome and exome sequencing method captures genetic variation in an unbiased and cost-effective manner.

Nature genetics·2026
Same author

Severe anaemia and invasive bacterial infections in Kenyan children: a 26-year hospital surveillance observational study.

The Lancet. Global health·2026
Same author

Lung function among children and adolescents with sickle cell disease living in Lake Victoria basin in Kenya.

Frontiers in pediatrics·2026
Same author

Burden of Neurodevelopmental Disorders in Kenyan Children.

JAMA network open·2025
Same author

Correction: Evaluation of the Psychometric Properties of the Social Communication Questionnaire in Rural Kenya.

Journal of autism and developmental disorders·2025

Area of Science:

  • Neurology
  • Infectious Diseases
  • Global Health

Background:

  • Cerebral malaria is a leading cause of nontraumatic encephalopathy worldwide, disproportionately affecting children in sub-Saharan Africa but increasingly seen in adults globally.
  • Significant differences exist in clinical presentation and pathophysiology between African children and nonimmune adults.
  • The condition carries a high mortality rate of 10-20%.

Purpose of the Study:

  • To review the current understanding of cerebral malaria, focusing on pathophysiology, clinical presentation, and treatment strategies.
  • To evaluate the efficacy of existing and potential therapeutic interventions, including antimalarials and ancillary treatments.
  • To identify gaps in knowledge and areas requiring further research for improved patient outcomes.

Main Methods:

Related Experiment Videos

  • Review of existing literature on cerebral malaria, including clinical studies and pathophysiological research.
  • Analysis of treatment outcomes associated with parenteral antimalarials (cinchona alkaloids, artemisinins) and adjunctive therapies.
  • Evaluation of evidence supporting or refuting the use of specific ancillary treatments like corticosteroids and deferoxamine.

Main Results:

  • Parenteral antimalarials are the only interventions proven to impact cerebral malaria outcomes.
  • Quinine and quinidine remain mainstays, with artemisinin derivatives gaining prominence.
  • Aggressive seizure management is vital, especially in children. Ancillary treatments show potential but lack rigorous trial support.

Conclusions:

  • Parenteral antimalarials are essential for treating cerebral malaria.
  • Further research is needed for ancillary treatments that target pathophysiological mechanisms to prevent neurological sequelae and mortality.
  • Corticosteroids and deferoxamine have limited evidence supporting their use in cerebral malaria.